Status:
NO_LONGER_AVAILABLE
Compassionate Use Study of Pergolide in Patients With Parkinson's Disease
Lead Sponsor:
Bausch Health Americas, Inc.
Conditions:
Parkinson Disease
Eligibility:
All Genders
Brief Summary
This compassionate use study is designed to monitor safety in patients who have been doing well on pergolide therapy, wish to continue treatment, and have not been able to tolerate alternative treatme...
Eligibility Criteria
Inclusion
- Diagnosed with Parkinson's disease and treated successfully with pergolide in the recent past
- Attempt to taper off pergolide was unsuccessful and patient was unable to change to other forms of therapy for Parkinson's disease
- No evidence of cardiovalvular disease by echocardiogram conducted within 60 days prior
Exclusion
- History or current diagnosis of cardiac valvulopathy
- Inability to undergo echocardiograms every 6 months while receiving pergolide
- Hypersensitivity to pergolide or other ergot derivatives
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00624741
Last Update
June 22 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.